- Home
- AARD vs CPHC Comparison
AARD vs CPHC Comparison
Compare AARD & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AARD | CPHC |
|---|---|---|
| Founded | 2017 | 1994 |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.7M | 79.9M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | AARD | CPHC |
|---|---|---|
| Price | $6.09 | $15.96 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $15.29 | N/A |
| AVG Volume (30 Days) | ★ 127.6K | 1.1K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $59,227,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.14 |
| 52 Week Low | $3.35 | $14.49 |
| 52 Week High | $17.94 | $21.61 |
Technical Indicators
Market Signals| Indicator | AARD | CPHC |
|---|---|---|
| Relative Strength Index (RSI) | 59.59 | 60.12 |
| Support Level | $4.81 | $15.91 |
| Resistance Level | $11.37 | $15.99 |
| Average True Range (ATR) | 0.40 | 0.16 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 90.70 | 86.10 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the real estate development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.